Skip to Content

Immunotech Laboratories Inc IMMB Stock Quote

| Rating as of


Last close prices updated as of May 08, 2023, 10:19 AM EST | USD
  • Last Close 0.0002
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range < 0.01  –  < 0.01
  • Year Range < 0.01  –  < 0.01
  • Market Cap 110.1320
  • Volume / Avg 5,799.0 /  3,036.0
  • Price / Sales 0.00
  • Price / Book < 0.01
  • Forward Div Yield 5.18%
  • Trailing Div Yield

Morningstar‘s Stock Analysis IMMB

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics IMMB

Company Profile IMMB

Business Description

Immunotech Laboratories Inc. is an organization with full indefinite licensing rights of the Irreversible Pepsin Fraction peptide molecule for the specific treatment and preventing of the HIV/AIDS indication.

116 W. Stocker Street
Glendale, CA, 91202
Industry Biotechnology
Employees 4

Competitors & Peers IMMB

Morningstar does not cover competitors or peers for this firm.

FAQs for Immunotech Laboratories Inc Stock

No. IMMB does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

IMMB’s market cap is 110.13.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

IMMB’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare IMMB’s historical performance against its industry peers and the overall market.